¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Complement System Proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • renin-angiotensin-aldosterone system
    ·¹´Ñ-¾ØÁö¿ÀÅÙ½Å-¾Ëµµ½ºÅ׷аèÅë
  • reproductive system
    »ý½Ä°èÅë, »ý½Ä°è
  • respiratory system
    È£Èí°èÅë, È£Èí°è
  • reticuloendothelial system
    ±×¹°³»ÇǰèÅë, ¸Á»ó³»Çǰè
  • review of system
    ü°èº°¹®Áø
  • Rh blood group system
    RhÇ÷¾×Çüü°è
  • somatosensory system
    ¸ö°¨°¢°èÅë, ü¼º°¨°¢°è
  • static system
    Á¤Áö°è
  • scavenging system
    Á¦°Åü°è, û¼Òü°è
  • stereotactic system
    1. Á¤À§°íÁ¤±â 2. Á¤À§Ã¼°è, ÀÔüü°è
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë, Ç¥Àç±Ù°Ç¸·°èÅë
  • superficial musculo-aponeurotic system platysma flap
    ¾ó±¼³ÎÈûÁÙ°èÅë³ÐÀº¸ñ±ÙÆÇ, Ç¥Àç±Ù°Ç¸·°èÅëȰ°æ±ÙÆÇ
  • system
    1. °èÅë, °è, ü°è 2. ÀåÄ¡ 3. Á¦µµ, ¹ý 4. ºÐ·ù¹ý
  • system analysis
    °èÅëºÐ¼®
  • self-system
    ÀÚ±âü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immune system
    ¸é¿ªÃ¼°è
  • impulse conducting system
    ½ÉÀåÈïºÐÀüµµ°èÅë
  • information system
    Á¤º¸Ã¼°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
  • integumentary system
    ÇǺΰèÅë
  • interofective system
    ³»ºÎȯ°æÁ¶Àý°è
  • interrenal system
    ºÎ½Å°ÑÁú°è
  • intrarenal collecting system
    ÄáÆÏ¼ÓÁý´¢°è
  • irrigation-aspiration system
    °ü·ùÈíÀÔÀåÄ¡
  • limbic system
    °¡ÀåÀÚ¸®°èÅë, º¯¿¬°è
  • local health system
    Áö¹æÀÇ·áü°è
  • lymphatic system
    ¸²ÇÁ°èÅë
  • macrophage system
    Å«Æ÷½Ä¼¼Æ÷°èÅë
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°è
  • metric system
    ¹ÌÅ͹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è.
  • heterogeneous system
    ºÒ±ÕÀϰè, ºÒ±ÕÁú°è.
  • hexagonal system
    À°¹æ°áÁ¤°è.
  • homogeneous system
    ±ÕÁú°è, ±ÕÀϰè.
  • hospital information system
    º´¿øÁ¤º¸Ã¼°è.
  • hydrophilic system
    Ä£¼ö°è(öÑâ©Í§).
  • hypophyseal portal system
    ³úÇϼöü¹®¸Æ°èÅë, Çϼöü¹®¸Æ°è(¡­Ú¦ØæÍ§).
  • hypothalamohypophyseal portal system
    ½Ã»óÇϺγúÇϼöü¹®¸Æ°è.
  • hypothalamohypophyseal system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamopituitary system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamus pituaitary system
    ½Ã»óÇϺγúÇϼöü°è.
  • imitation gold of brass system
    Ȳµ¿°è¸ðÁ¶±Ý(üÜÔÞͧټðãÐÝ).
  • immersion system
    ¾×ħ°è(äûöÙͧ).
  • immobilization system
    °íÁ¤¹æ½Ä
  • immune system
    ¸é¿ª°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • biliary system
    ´ã°ü°è(´ã°ü°è), ´ãµµ°è(´ãµµ°è).
  • biliary system(tract)
    ´ãµµ°è(ÓÅԳͧ)
  • bioenergetic system
    »ý¹°¿¡³ÊÁö°è.
  • blood group system
    Ç÷¾×Çü±º
  • breathing system
    È£ÈíÀåÄ¡(¡­íûöÇ).
  • buffer system
    ¿ÏÃæ°è
  • capitation system
    ÀεÎÁ¦, ȯÀÚµî·ÏÁ¦.
  • cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
  • cardiac conduction system
    ½ÉÀå ÈïºÐ Àüµµ°è(ãýíôýéÝÇîîÓôͧ)
  • cardiovascular system
    ½ÉÇ÷°ü°è(ãýúìμÌõ)
  • cardiovascular system
    ½ÉÇ÷°ü°è(ãýúìηͧ)
  • cardiovascular system
    ¼øÈ¯°èÅë
  • case payment system
    Æ÷°ý¼ö°¡Á¦
  • central nervous system
    ÁßÃ߽Űæ°è(ñéõÒãêÌèͧ)
  • central nervous system
    ÁßÃ߽Űæ°èÅë, ÁßÃ߽Űæ°è(ñéõÒãêÌèͧ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CF test Complement Fixation test; º¸Ã¼°áÇÕ¹ý
CH50 Hemolytic Complement 50; ¿ëÇ÷ º¸Ã¼ °Ë»ç¹ý; (30)50 - (40)(66)80 Unit/mL
Gc globulin Group-specific complement globulin
AC abdominal circumference; abdominal compression; absorption coefficient; abuse case; acetate; acetylc...
AICF autoimmune complement fixation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
SASP Small, acid-soluble proteins
SCP Sterol Carrier Proteins
SP Stress proteins
SCOP Structural Classification of Proteins
SP-D Surfactant proteins A and D
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neural enzyme system
    ½Å°æ È¿¼Ò°è
  • neuromuscular system
    ±Ù½Å°æ°è, ½Å°æ ±ÙÀ°°è
  • non-noxious cutaneous stimulation system
    ºñÀ¯Çؼº ÇǺΠÀڱذè
  • non-painful cutaneous stimulation system
    ºñÅëÁõ¼º Àڱذè
  • non-specific arousal system
    ºñƯÀ̼º °¢¼º°è
  • occlusal system
    ÀÇÄ¡ ÀΰøÄ¡ ±³ÇÕ¸é ¹è¿­ ü°è
    ÀÇÄ¡¿¡¼­ ÀüÄ¡¿Í ±¸Ä¡ÀÇ °¢ Ä¡¾ÆÀÇ Çüųª µðÀÚÀÎ, ÀüüÀû ¹è¿­ µî.
  • oil immersion system
    À¯Ä§ ÀåÄ¡
  • open vessel system
    °³¹æ ¼øÈ¯°è
  • opiate sensitive system
    ¾ÆÆí¼º °¨¼º°è
  • opioid-mediated analgesia system
    ¾ÆÆí ¸Å°³ ÁøÅë°è
  • osseous system
    »À ±â°ü, °ñ°è
  • oxidation reduction system
    »êÈ­ ȯ¿ø°è
  • pain system
    µ¿Åë°è
  • pain transmission system
    µ¿Åë Àü´Þ°è
  • pain-modulating system
    µ¿Åë Á¶Àý°è
    ÁßÃß ½Å°æ°è´Â Åë°¢À» Àü´ÞÇÏ¿© ÅëÁõÀ» ´À³¢°Ô ÇÏ´Â ±â´É À̿ܿ¡µµ µ¿ÅëÀ» ÅëÁ¦ÇÏ´Â ÀÏ·ÃÀÇ ½Å°æ Á¶Á÷À» °®°í ÀÖÀ¸¸ç, ½Å°æ ¼¼Æ÷¿¡¼­ o
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
membrane proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
(12 Dec 1998)
retroviridae proteins Proteins from the family retroviridae. The most frequently encountered member of this family is the rous sarcoma virus protein.
(12 Dec 1998)
retroviridae proteins, oncogenic Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukaemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.
(12 Dec 1998)
chimeric proteins Proteins in individuals that are derived from genetically different zygotes.
(12 Dec 1998)
peripheral proteins Pathways that can be easily removed from a biomembrane (e.g., by altering the pH or the ionic strength).
Synonym: extrinsic proteins.
(05 Mar 2000)
periplasmic binding proteins Transport proteins located within the periplasmic space. Some act as receptors for bacterial chemotaxis, interacting with MCPs. Their mode of action is unclear.
(18 Nov 1997)
ribosomal proteins Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.
(12 Dec 1998)
growth associated proteins <growth factor> Group of developmentally regulated polypeptides thought to be critical for the formation of neural circuitry. The acidic membrane phosphoprotein GAP 43 is synthesised and transported down regenerating and developing axons, pp46 localised in growth cone membranes during embryogenesis, B 50 in mature presynaptic membranes in the regulation of phosphotidylinositol turnover and F1 in the hippocampus during long-term potentiation, are now all known to be the same protein.
(18 Nov 1997)
RNA-binding proteins Proteins which bind to RNA molecules. Certain structure motifs are common to several of the proteins, such as arginine (arg)-rich tracts, typically consisting of alternating arg-asp, arg-ser, or arg-gly residues. These proteins also tend to have a common ribonucleotide sequence domain.
(12 Dec 1998)
cholesterol ester transport proteins A protein that transports cholesterol esters from HDL to VLDL and LDL; a deficiency of this protein is associated with elevated HDL cholesterol.
(05 Mar 2000)
chromosomal proteins, non-histone Nucleoproteins which in contrast to histones are acid insoluble. They are involved in chromosomal functions; e.g. They bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.
(12 Dec 1998)
microfilament proteins Filaments which are composed primarily of actin and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.
(12 Dec 1998)
microtubule-associated proteins <protein> High molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilise the assembled microtubules.
Acronym: MAP
(12 Dec 1998)
milk proteins The major protein constituents of milk are caseins and whey proteins such as lactalbumin and lactoglobulins. Immunoglobulins occur in high concentrations in colostrum and in relatively lower concentrations in milk.
(12 Dec 1998)
phosphorylation of proteins <biochemistry> Addition of phosphate groups to hydroxyl groups on proteins (side chains s, T or Y) catalysed by a protein kinase often specific) with ATP as phosphate donor. Activity of proteins is often regulated by phosphorylation.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • reticuloendothelial system
    (¼¼)¸Á ³»(ÇÇ)°è
  • retrieval system
    Á¤º¸ °Ë»ö ½Ã½ºÅÛ
  • solar system
    žç°è
  • spoils system
    ¿±°ü Á¦µµ(¿©´çÀÌ Â÷ÁöÇÏ´Â)
  • sprinkler system
    ÀÚµ¿ »ì¼ö ¼ÒÈ­ ÀåÄ¡
  • stagger system
    (ÃâÅð±Ù ½Ã°£ µûÀ§ÀÇ)½ÃÂ÷Á¦
  • system
    Á¶Á÷;ü°è;°èÅë;Çм³;Á¦µµ;¹æ½Ä;¹æ¹ý;¼ø¼­;°è;¿ìÁÖ
  • talkingdown system
    ¹«Àü À¯µµ ¹æ½Ä
  • track system
    Çзº° ¹ÝÆí¼º
  • truck system
    (ÀÓ±ÝÀÇ) Çö¹° Áö±ÞÁ¦
  • twoparty system
    2´ë Á¤´çÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á